Literature DB >> 27139486

Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.

Danielle M Zerr1, Arianna Miles-Jay2, Matthew P Kronman3, Chuan Zhou3, Amanda L Adler4, Wren Haaland4, Scott J Weissman3, Alexis Elward5, Jason G Newland6, Theoklis Zaoutis7, Xuan Qin8.   

Abstract

The objective of this study was to determine whether antibiotic exposure is associated with extended-spectrum-beta-lactamase- or AmpC-producing Escherichia coli or Klebsiella pneumoniae infections in children. We collected extended-spectrum-beta-lactamase- or AmpC-producing E. coli or K. pneumoniae isolates and same-species susceptible controls from normally sterile sites of patients aged ≤21 years, along with associated clinical data, at four free-standing pediatric centers. After controlling for potential confounders, the relative risk of having an extended-spectrum-beta-lactamase-producing isolate rather than a susceptible isolate was 2.2 times higher (95% confidence interval [CI], 1.49 to 3.35) among those with antibiotic exposure in the 30 days prior to infection than in those with no antibiotic exposure. The results were similar when analyses were limited to exposure to third-generation cephalosporins, other broad-spectrum beta-lactams, or trimethoprim-sulfamethoxazole. Conversely, the relative risk of having an AmpC-producing versus a susceptible isolate was not significantly elevated with any antibiotic exposure in the 30 days prior to infection (adjusted relative risk ratio, 1.12; 95% CI, 0.65 to 1.91). However, when examining subgroups of antibiotics, the relative risk of having an AmpC-producing isolate was higher for patients with exposure to third-generation cephalosporins (adjusted relative risk ratio, 4.48; 95% CI, 1.75 to 11.43). Dose-response relationships between antibiotic exposure and extended-spectrum-beta-lactamase-producing or AmpC-producing isolates were not demonstrated. These results reinforce the need to study and implement pediatric antimicrobial stewardship strategies, and they indicate that epidemiological studies of third-generation cephalosporin-resistant E. coli and K. pneumoniae isolates should include resistance mechanisms when possible.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27139486      PMCID: PMC4914666          DOI: 10.1128/AAC.00187-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance.

Authors:  Keith S Kaye; Anthony D Harris; Matthew Samore; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2005-04       Impact factor: 3.254

3.  Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli in an urban county hospital.

Authors:  Sarah B Doernberg; Lisa G Winston
Journal:  Am J Infect Control       Date:  2011-07-20       Impact factor: 2.918

4.  Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.

Authors:  Jesús Rodríguez-Baño; Encarnación Picón; Paloma Gijón; José Ramón Hernández; Maite Ruíz; Carmen Peña; Manuel Almela; Benito Almirante; Fabio Grill; Javier Colomina; Monserrat Giménez; Antonio Oliver; Juan Pablo Horcajada; Gemma Navarro; Ana Coloma; Alvaro Pascual
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

5.  Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Hyunjoo Pai; Cheol-In Kang; Jeong-Hum Byeon; Ki-Deok Lee; Wan Beom Park; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.

Authors:  Noam Dayan; Husein Dabbah; Irith Weissman; Ibrahim Aga; Lea Even; Daniel Glikman
Journal:  J Pediatr       Date:  2013-08-03       Impact factor: 4.406

7.  Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.

Authors:  S P Kuster; B Hasse; V Huebner; V Bansal; R Zbinden; C Ruef; B Ledergerber; R Weber
Journal:  Infection       Date:  2010-01-27       Impact factor: 3.553

8.  Epidemiology and characteristics of urinary tract infections in children and adolescents.

Authors:  Rima H Hanna-Wakim; Soha T Ghanem; Mona W El Helou; Sarah A Khafaja; Rouba A Shaker; Sara A Hassan; Randa K Saad; Carine P Hedari; Rima W Khinkarly; Farah M Hajar; Marwan Bakhash; Dima El Karah; Imad S Akel; Mariam A Rajab; Mireille Khoury; Ghassan S Dbaibo
Journal:  Front Cell Infect Microbiol       Date:  2015-05-26       Impact factor: 5.293

9.  Characterization of Plasmid-Mediated AmpC and Carbapenemases among Iranain Nosocomial Isolates of Klebsiella pneumoniae Using Phenotyping and Genotyping Methods.

Authors:  Alireza Japoni-Nejad; Ehsanollah Ghaznavi-Rad; Alex van Belkum
Journal:  Osong Public Health Res Perspect       Date:  2014-11-13

10.  Plasmid-mediated AmpC: prevalence in community-acquired isolates in Amsterdam, the Netherlands, and risk factors for carriage.

Authors:  E Ascelijn Reuland; Teysir Halaby; John P Hays; Denise M C de Jongh; Henrieke D R Snetselaar; Marte van Keulen; Petra J M Elders; Paul H M Savelkoul; Christina M J E Vandenbroucke-Grauls; Nashwan Al Naiemi
Journal:  PLoS One       Date:  2015-01-14       Impact factor: 3.240

View more
  16 in total

Review 1.  The Growing Threat of Antibiotic Resistance in Children.

Authors:  Rachel L Medernach; Latania K Logan
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

2.  A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Authors:  Anna C Sick-Samuels; Katherine E Goodman; Glenn Rapsinski; Elizabeth Colantouni; Aaron M Milstone; Andrew J Nowalk; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2020-04-30       Impact factor: 3.164

3.  Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.

Authors:  Sibani Das; Amanda L Adler; Arianna Miles-Jay; Matthew P Kronman; Xuan Qin; Scott J Weissman; C A Burnham; Alexis Elward; Jason G Newland; Rangaraj Selvarangan; Kaede V Sullivan; Theoklis Zaoutis; Danielle M Zerr
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Whole Genome Sequencing Detects Minimal Clustering Among Escherichia coli Sequence Type 131-H30 Isolates Collected From United States Children's Hospitals.

Authors:  Arianna Miles-Jay; Scott J Weissman; Amanda L Adler; Janet G Baseman; Danielle M Zerr
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

5.  Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.

Authors:  Arianna Miles-Jay; Scott J Weissman; Amanda L Adler; Veronika Tchesnokova; Evgeni V Sokurenko; Janet G Baseman; Danielle M Zerr
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

6.  The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Authors:  Danielle M Zerr; Scott J Weissman; Chuan Zhou; Matthew P Kronman; Amanda L Adler; Jessica E Berry; Jaipreet Rayar; Jeff Myers; Wren L Haaland; Carey-Ann D Burnham; Alexis Elward; Jason Newland; Rangaraj Selvarangan; Kaede V Sullivan; Theoklis Zaoutis; Xuan Qin
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

7.  Novel chromosomal insertions of ISEcp1-blaCTX-M-15 and diverse antimicrobial resistance genes in Zambian clinical isolates of Enterobacter cloacae and Escherichia coli.

Authors:  Misheck Shawa; Yoshikazu Furuta; Gillan Mulenga; Maron Mubanga; Evans Mulenga; Tuvshinzaya Zorigt; Christone Kaile; Manyando Simbotwe; Atmika Paudel; Bernard Hang'ombe; Hideaki Higashi
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-10       Impact factor: 4.887

8.  Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients: A Nested Case-Control Study.

Authors:  Giuseppe Migliara; Valentina Baccolini; Claudia Isonne; Sara Cianfanelli; Carolina Di Paolo; Annamaria Mele; Lorenza Lia; Angelo Nardi; Carla Salerno; Susanna Caminada; Vittoria Cammalleri; Francesco Alessandri; Guglielmo Tellan; Giancarlo Ceccarelli; Mario Venditti; Francesco Pugliese; Carolina Marzuillo; Corrado De Vito; Maria De Giusti; Paolo Villari
Journal:  Antibiotics (Basel)       Date:  2021-03-15

9.  A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.

Authors:  Sevgen Tanır Basaranoglu; Yasemin Ozsurekci; Kubra Aykac; Eda Karadag Oncel; Asiye Bıcakcigil; Banu Sancak; Ali Bulent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  Ital J Pediatr       Date:  2017-09-12       Impact factor: 2.638

10.  Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.

Authors:  Shamim Islam; Rangaraj Selvarangan; Neena Kanwar; Rendie McHenry; James D Chappell; Natasha Halasa; Mary E Wikswo; Daniel C Payne; Parvin H Azimi; L Clifford McDonald; Oscar G Gomez-Duarte
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.